ストックスクリーナーアプリを入手
17.49
0.98%
0.17
アフターアワーズ：
14.00
-3.49
-19.95%
前日終値:
$17.32
開ける：
$17.52
24時間の取引高:
1.76M
Relative Volume:
1.18
時価総額：
$1.19B
収益：
$2.73B
当期純損益:
$-1.13B
株価収益率:
-1.0497
EPS:
-16.6622
ネットキャッシュフロー:
$-83.00M
1週間 パフォーマンス:
+14.16%
1か月 パフォーマンス:
+2.28%
6か月 パフォーマンス:
-35.96%
1年 パフォーマンス:
-34.15%
1日の値動き範囲:
$17.26
$18.00
1週間の範囲:
$13.70
$18.00
52週間の値動き範囲:
$13.70
$38.99
Quidelortho Corporation Stock (QDEL) Company Profile
名前
Quidelortho Corporation
セクター
電話
(858) 552-1100
住所
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
17.49 | 1.18B | 2.73B | -1.13B | -83.00M | -16.66 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-07 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-05-08 | アップグレード | Jefferies | Hold → Buy |
| 2024-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2024-12-10 | 開始されました | Jefferies | Hold |
| 2024-09-19 | 再開されました | UBS | Neutral |
| 2024-09-05 | アップグレード | Craig Hallum | Hold → Buy |
| 2024-03-04 | ダウングレード | UBS | Neutral → Sell |
| 2024-02-14 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-14 | アップグレード | UBS | Sell → Neutral |
| 2022-09-19 | 開始されました | Citigroup | Neutral |
| 2022-07-20 | 開始されました | UBS | Sell |
| 2022-06-17 | 再開されました | JP Morgan | Neutral |
| 2022-02-22 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-03-26 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2018-10-23 | 再開されました | Raymond James | Strong Buy |
| 2018-03-08 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | 繰り返されました | Barclays | Overweight |
| 2018-01-04 | アップグレード | CL King | Neutral → Buy |
| 2017-09-19 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | 繰り返されました | Canaccord Genuity | Hold |
| 2017-02-17 | 開始されました | CL King | Neutral |
| 2016-12-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | 繰り返されました | Barclays | Overweight |
| 2016-02-09 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | 繰り返されました | Canaccord Genuity | Buy |
| 2015-12-14 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | 開始されました | Barclays | Overweight |
| 2013-07-31 | 繰り返されました | Canaccord Genuity | Buy |
| 2011-03-03 | ダウングレード | Wedbush | Outperform → Neutral |
すべてを表示
Quidelortho Corporation (QDEL) 最新ニュース
QuidelOrtho (QDEL) Projects Lower Q1 2026 Revenue Amid Weaker De - GuruFocus
QuidelOrtho (QDEL) Sees 12% Drop Following Disappointing Q1 Reve - GuruFocus
QuidelOrtho announces preliminary revenue for the first quarter 2026 and provides update on full-year 2026 guidance - marketscreener.com
QuidelOrtho announces preliminary revenue for the first quarter of 2026 and updates its full-year 2026 performance outlook. - 富途牛牛
QuidelOrtho (QDEL) Projects Q1 2026 Revenue Impacted by Market C - GuruFocus
QuidelOrtho Expects Q1 Revenue of $615 Million-$620 Million; Shares Fall After Hours - marketscreener.com
QuidelOrtho stock plunges on weak revenue guidance By Investing.com - Investing.com Australia
QuidelOrtho stock plunges on weak revenue guidance - Investing.com
QuidelOrtho reports preliminary Q1 2026 revenue of $615-620 million - StreetInsider
QuidelOrtho (NASDAQ: QDEL) guides Q1 revenue $615–620M with negative free cash flow - Stock Titan
Weaker flu season weighs on QuidelOrtho as Q1 sales fall below $620M - Stock Titan
QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $14.00 - Markets Mojo
QuidelOrtho Corp. Hits Day Low at $14 Amid Price Pressure - Markets Mojo
QuidelOrtho Corp (QDEL) Shares Surge 7.7% -- What GF Score of 63 Tells Investors - GuruFocus
Volatility Watch: Is QuidelOrtho Corporation a defensive stockMarket Activity Summary & Precise Trade Entry Recommendations - baoquankhu1.vn
QuidelOrtho (NASDAQ:QDEL) Cut to "Hold" at Wall Street Zen - MarketBeat
QuidelOrtho, Lifotronic Technology to Expand Global Immunoassay Portfolio - Medical Product Outsourcing
Today's Analyst Rating Update for QuidelOrtho (QDEL) | QDEL Stoc - GuruFocus
UBS cuts Quidel stock price target on weaker respiratory season By Investing.com - Investing.com India
UBS cuts Quidel stock price target on weaker respiratory season - Investing.com
UBS Adjusts Price Target on QuidelOrtho to $17 From $30, Maintains Neutral Rating - marketscreener.com
UBS Maintains QuidelOrtho(QDEL.US) With Hold Rating, Cuts Target Price to $17 - Moomoo
QuidelOrtho (QDEL) Is Down 18.0% After Proposed NIH Funding Cuts Raised Diagnostics Demand Questions - Sahm
Quidel Corporation stock hits 52-week low at 14.43 USD By Investing.com - Investing.com Australia
QuidelOrtho (QDEL) Is Down 7.6% After Proposed US Health Funding Cuts Raise Policy Uncertainty - Yahoo Finance
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories stocks trade down, what you need to know - MSN
Assessing QuidelOrtho (QDEL) Valuation After Recent Share Price Volatility - Yahoo Finance
Weekly Earnings: Will QuidelOrtho Corporation benefit from rising consumer demandMarket Performance Report & Consistent Growth Equity Picks - baoquankhu1.vn
How does QuidelOrtho Corporation compare to its peers2026 Trading Recap & Long-Term Capital Growth Strategies - baoquankhu1.vn
Is It Time To Reassess QuidelOrtho (QDEL) After The Recent Share Price Slump? - simplywall.st
QuidelOrtho Corporation (QDEL) stock price, news, quote and history - Yahoo Finance UK
QuidelOrtho Corp (QDEL) Trading Down 5.04% on Apr 6 - GuruFocus
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Shares Down 3.6%Should You Sell? - MarketBeat
QuidelOrtho Corporation (QDEL) Stock Price, News, Quote & History - Yahoo! Finance Canada
QuidelOrtho Corporation $QDEL Shares Sold by JPMorgan Chase & Co. - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Rating Increased to Buy at Wall Street Zen - MarketBeat
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell shares are falling, what you need to know - MSN
QuidelOrtho Corp Stock: Navigating Diagnostics Leadership Amid Sector Evolution and Investor Opportu - AD HOC NEWS
Aug Final Week: Is QuidelOrtho Corporation a defensive stock2026 Trading Volume Trends & Accurate Buy Signal Alerts - baoquankhu1.vn
Buyback Watch: Why is QuidelOrtho Corporation stock going downWeekly Trend Report & Real-Time Price Movement Reports - baoquankhu1.vn
QuidelOrtho Corporation (QDEL) Stock forecasts - Yahoo Finance UK
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $14.45 - Markets Mojo
Value Recap: Does QuidelOrtho Corporation offer margin of safetyMarket Growth Report & Verified Stock Trade Ideas - baoquankhu1.vn
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $17.08 - Markets Mojo
Precision Trading with Quidelortho Corp Com (QDEL) Risk Zones - Stock Traders Daily
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares of QuidelOrtho (QDEL) - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Reaches New 12-Month LowHere's What Happened - MarketBeat
Why is QuidelOrtho (QDEL) down 24.5% since last earnings report? - MSN
QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo Finance
Quidelortho Corporation (QDEL) 財務データ
収益
当期純利益
現金流量
EPS
2.40%
0.00%
大文字化:
|
ボリューム (24 時間):